Deep Vein Thrombosis (DVT): Overview and Practice Questions

A deep vein thrombosis (DVT) is a serious medical condition in which a blood clot forms in the deep veins, most often in the legs. While it may seem like an isolated vascular issue, DVT carries significant risks because the clot can break free and travel to the lungs, causing a life-threatening pulmonary embolism. This makes early recognition, prevention, and management critically important in healthcare.

For respiratory therapists, understanding DVT is especially relevant since its complications directly affect the lungs and a patient’s ability to breathe effectively. By exploring what a DVT is and its significance in respiratory care, we can gain a deeper understanding of its impact on patient outcomes.

Free Access

RRT Course and Quiz Bundle (Free)

Get free access to 15+ premium courses and quizzes that cover the most essential topics to help you become a Registered Respiratory Therapist (RRT).

Get Free Access

What is Deep Vein Thrombosis?

Deep vein thrombosis (DVT) is a medical condition in which a blood clot (thrombus) forms in a deep vein, most commonly in the legs. These clots can cause pain, swelling, redness, and warmth in the affected area, though sometimes a DVT can be asymptomatic. The real danger of a DVT is that the clot can dislodge, travel through the venous system, and block blood flow in the lungs, leading to a pulmonary embolism (PE), which is a life-threatening emergency.

Risk factors for a DVT include immobility (such as during long hospital stays), recent surgery, trauma, pregnancy, obesity, smoking, cancer, use of oral contraceptives, and genetic clotting disorders. Preventing a DVT is a key focus in patient care, especially for those who are hospitalized or critically ill.

Why is DVT Relevant to Respiratory Therapists?

While a DVT originates in the circulatory system, it directly impacts the respiratory system through its link to a pulmonary embolism. Since respiratory therapists specialize in assessing and treating pulmonary complications, understanding DVT is essential for their role in patient care.

• Pulmonary Embolism (PE) and Respiratory Failure: A dislodged clot can obstruct pulmonary arteries, leading to hypoxemia, increased dead space ventilation, and impaired gas exchange. Severe PEs can trigger acute respiratory distress, hemodynamic instability, or even sudden death. RTs are often among the first to recognize unexplained shortness of breath, tachypnea, hypoxemia, or changes in ABG values that may indicate PE.
• Mechanical Ventilation Considerations: Many patients at risk for a DVT are those requiring prolonged bed rest, sedation, or mechanical ventilation. Immobility significantly increases clot risk. RTs can advocate for early mobilization, spontaneous breathing trials, and proper ventilator weaning to reduce immobility-related risks.
• Patient Assessment: RTs frequently monitor patients for unexplained changes in oxygenation, ventilation, and work of breathing. Recognizing signs of pulmonary embolism secondary to a DVT is vital for timely escalation of care. They may observe sudden desaturation, increased dead space on capnography, or unexplained dyspnea—clues that can point toward PE.
• Preventive Measures: While physicians and nurses primarily manage DVT prevention strategies (such as anticoagulation, compression stockings, and pneumatic devices), RTs play a supportive role by minimizing patient immobility, optimizing oxygenation, and reducing complications that increase the risk of clot formation.

DVT in the Broader Scope of Respiratory Care

Respiratory therapists are an integral part of the multidisciplinary healthcare team. Their understanding of a DVT goes beyond pulmonary embolism—it connects to patient safety, outcomes, and holistic care.

By linking vascular health to respiratory complications, RTs strengthen their role as frontline professionals in detecting life-threatening conditions.

Ultimately, awareness of a DVT allows respiratory therapists to:

• Recognize at-risk patients.
• Interpret early warning signs of pulmonary embolism.
• Collaborate with physicians and nurses to implement preventive strategies.
• Provide timely intervention that may save lives.

By maintaining vigilance around DVT, respiratory therapists not only safeguard pulmonary function but also contribute to comprehensive patient safety.

This proactive approach highlights their essential role in bridging cardiovascular and respiratory care, ensuring patients receive the best possible outcomes.

Deep Vein Thrombosis (DVT) Practice Questions

1. What is a deep vein thrombosis (DVT)?  
A DVT is the formation of a blood clot (thrombus) in the deep veins, typically in the lower limbs.

2. Where do most DVTs typically occur?  
Most DVTs develop in the deep veins of the lower extremities, especially the legs.

3. What is considered a distal DVT?  
A distal DVT occurs below the knee, typically involving the calf veins below the popliteal trifurcation.

4. What is considered a proximal DVT?  
A proximal DVT involves the veins at or above the knee, such as the popliteal or femoral veins.

5. What percentage of patients with a proximal DVT will develop a pulmonary embolism (PE) within 3 months if untreated?  
Approximately 50% of patients with a proximal DVT may develop a PE within 3 months.

6. Up to what percentage of cancer patients develop a DVT?  
Up to 20% of cancer patients are at risk of developing a DVT.

7. What are some intrinsic (non-modifiable) risk factors for developing a DVT?
History of DVT, cancer, obesity, inherited thrombophilia, inflammatory conditions, varicose veins, smoking, male sex, and age over 60.

8. What are some transient (modifiable) risk factors for DVT?  
Recent surgery or trauma, long-haul travel, immobility, pregnancy, hospitalization, and use of estrogen-based hormone therapy (COCP or HRT).

9. What are thrombophilias?  
Thrombophilias are inherited or acquired conditions that increase the risk of abnormal blood clotting due to excessive clotting factors or deficient anticoagulants.

10. What are examples of thrombophilic disorders that increase DVT risk?  
Examples include Factor V Leiden mutation, antiphospholipid syndrome, and antithrombin deficiency.

11. What are the classic symptoms associated with DVT?  
Unilateral leg pain, swelling, warmth, and erythema (redness) of the affected limb.

12. What are common physical signs of a DVT?  
Calf asymmetry greater than 3 cm, tenderness along deep veins, swelling, and visible venous distention.

13. What is the Wells score used for in DVT assessment?  
The Wells score is a clinical prediction tool used to estimate the probability of DVT in symptomatic patients.

14. A Wells score greater than what value suggests a likely DVT?  
A Wells score greater than 2 is considered high risk, but a score over 4 is often considered clinically significant.

15. What is the recommended investigation pathway for a patient with a Wells score less than 1?
Order a D-dimer test first; if it is positive, follow up with a proximal leg ultrasound.

16. What is a D-dimer?  
D-dimer is a fibrin degradation product that becomes elevated in the presence of active clot formation and breakdown.

17. What is the primary use of a D-dimer test in DVT diagnosis?  
It is used to rule out (exclude) the presence of a DVT in low-risk patients.

18. What imaging technique is commonly used to confirm a DVT diagnosis?  
A Doppler ultrasound is the primary diagnostic tool used to visualize blood flow and detect clots in deep veins.

19. In what other conditions can D-dimer levels be elevated?  
Elevated D-dimer can also be seen in pneumonia, cancer, heart failure, pregnancy, and post-surgical states.

20. What tests are commonly used to diagnose a pulmonary embolism (PE)?  
CT pulmonary angiography and ventilation-perfusion (V/Q) scanning are the main diagnostic tools for PE.

21. What are the three primary options for long-term anticoagulation in venous thromboembolism (VTE)?
Direct oral anticoagulants (DOACs), warfarin, and low molecular weight heparin (LMWH).

22. What is the initial pharmacologic treatment for a newly diagnosed DVT?  
Start with a DOAC such as apixaban or rivaroxaban unless contraindicated.

23. What does the abbreviation DOAC stand for?  
DOAC stands for Direct Oral Anticoagulant.

24. How long should anticoagulation therapy be continued for a provoked DVT?  
Anticoagulation should be continued for at least 3 months in cases of provoked DVT.

25. How long should anticoagulation therapy be continued for an unprovoked DVT?  
Patients with an unprovoked DVT should typically be treated with anticoagulation for at least 6 months.

26. What is considered an unprovoked DVT?  
An unprovoked DVT occurs in the absence of any known risk factors or triggering events.

27. How long should patients with cancer-associated DVT remain on anticoagulation therapy?  
Cancer patients with a DVT should typically receive anticoagulation for 3 to 6 months, or longer if the cancer is still active.

28. What is Budd-Chiari syndrome?  
Budd-Chiari syndrome is a rare condition involving thrombosis in the hepatic veins, which impairs liver drainage.

29. What is the classic triad of symptoms in Budd-Chiari syndrome?  
The triad includes abdominal pain, hepatomegaly (enlarged liver), and ascites (abdominal fluid buildup).

30. What is the most common reason for clinical evaluation of extremity veins?  
Suspected deep vein thrombosis (DVT) is the most common reason for evaluating extremity veins.

31. What is the estimated annual incidence of DVT in the United States?  
Approximately 2.5 million new cases of DVT occur each year.

32. About what percentage of untreated DVT patients develop a nonfatal pulmonary embolism (PE)?  
Approximately 25% of untreated DVT cases result in a nonfatal PE.

33. What direction do veins transport blood, and what additional functions do they serve?  
Veins carry blood back to the heart, help regulate body temperature, cardiac output, and serve as a blood reservoir.

34. What are family history risk factors associated with DVT?  
Family-related risk factors include smoking, COPD, blood type A, varicose veins, drug abuse, and May-Thurner syndrome.

35. What are common clinical indications of DVT?  
Signs include edema, pain, shortness of breath, skin discoloration, varicose veins, ulceration, hypercoagulable states, and a positive D-dimer test.

36. Why can DVT be difficult to visualize on imaging studies?  
Obesity, edema, and devices like casts or Unna boots can obstruct visualization of the veins.

37. What is coagulation?  
Coagulation is the process by which blood clumps together to prevent excessive bleeding after an injury.

38. What is anticoagulation?  
Anticoagulation is the process that prevents spontaneous or unwanted clot formation in blood vessels.

39. When a blood vessel is injured, what initially attaches to the damaged vessel wall?  
White blood cells (WBCs) are among the first to adhere to the site of injury.

40. What happens when prothrombin is activated?  
Prothrombin is converted to thrombin, which then converts fibrinogen into fibrin threads to form a stable blood clot.

41. How does blood stasis contribute to clot formation?  
Stasis allows blood to pool and coagulate, increasing the risk of clot formation.

42. What is meant by thrombus stabilization?  
Stabilization refers to a clot remaining attached to the vessel wall without growing or moving.

43. What does it mean if a thrombus propagates?  
Propagation means the thrombus is growing in size or extending to other parts of the vessel.

44. What is embolization of a thrombus?  
Embolization occurs when a portion or all of a thrombus breaks off and travels through the bloodstream, potentially causing a pulmonary embolism.

45. In which areas are DVTs most likely to form?  
DVTs commonly form in deep veins (e.g., FV, Popliteal, PTV), superficial veins (GSV, LSV), muscular veins (gastrocnemius, soleus), perforators, valve sites, and venous confluences.

46. What veins are classified as deep veins in the lower extremity?  
Deep veins include the common femoral vein (CFV), femoral vein (FV), profunda femoris (Prof), popliteal vein (Pop), peroneal, posterior tibial (PTV), and iliac veins.

47. What dual role does thrombin play in clot regulation?  
Thrombin activates fibrin formation (clot formation) and also stimulates the clot-dissolving (fibrinolytic) system for balance.

48. What are D-dimers?  
D-dimers are fragments of fibrin that result from the breakdown of blood clots by the body’s fibrinolytic system.

49. What does an elevated D-dimer level indicate?  
Elevated D-dimer levels suggest that the body’s clot-dissolving system has been activated, often due to clotting, infection, inflammation, or pregnancy.

50. What does a negative D-dimer test result indicate?  
A negative D-dimer result strongly suggests that there is no active clot formation, helping to rule out conditions like DVT.

51. What does an elevated d-Dimer test result indicate?  
An elevated d-Dimer does not confirm a clot but suggests further testing is needed to rule out DVT or PE.

52. What test is routinely used in the initial assessment of suspected venous thromboembolism (VTE)?  
The d-Dimer test is commonly used in the first-line evaluation of patients with suspected DVT or PE.

53. What result from a d-Dimer test can reliably exclude VTE in low-risk patients?  
A negative d-Dimer test can reliably rule out VTE in patients with low pre-test probability.

54. When imaging veins, what mindset should the examiner adopt compared to arterial imaging?
A different mindset is needed because the goal is to detect thrombus rather than assess blood flow.

55. What is the most important goal when performing venous imaging?  
To detect the presence or absence of thrombus and determine whether it is acute or chronic.

56. Why might a non-obstructive thrombus pose a greater risk of pulmonary embolism?  
Because it may be less adherent to the vein wall and more likely to break loose.

57. What are the two main goals when diagnosing venous thrombosis?  
Identify the presence of thrombus and assess the risk of embolization.

58. What are the three types of veins assessed during a duplex venous exam?
Deep veins, superficial veins, and perforator veins.

59. What type of veins are located within muscles, accompanied by an artery, and carry a higher PE risk?  
Deep veins.

60. What are the characteristics of superficial veins?  
They are not accompanied by arteries, help regulate body temperature, and are located close to the skin.

61. Can clots in superficial veins embolize to the lungs?  
Yes, clots can break free and travel from superficial veins into pulmonary arteries via the deep system.

62. What is the function of perforator veins?  
They connect superficial and deep veins, helping prevent blood pooling and are evaluated in cases of chronic swelling.

63. Once a thrombus is identified, what is the next step?  
Assess how firmly it is attached and its potential to embolize.

64. How does the age of a clot relate to its embolization risk?  
The newer the clot, the higher the risk of embolization.

65. What are ultrasound signs of an acute thrombus?  
Poorly attached, spongy texture, faintly echogenic, and vein dilation if totally obstructed.

66. What are characteristics of a chronic thrombus on imaging?  
Well-attached, hyperechoic, rigid, vein contraction, and presence of collateral circulation.

67. How does a newly formed thrombus appear on ultrasound?  
It is usually echogenic or nearly invisible.

68. How are acute clots sometimes detected during compression?  
By noting veins that do not fully compress but still have some spongy give due to recent clot formation.

69. How are acute clots typically described?  
Spongy and free-floating within the vein.

70. Why is it important to perform small, frequent compressions down the leg during scanning?  
Smaller increments reduce the chance of missing a thrombus.

71. In what imaging plane is most venous duplex imaging performed?  
Transverse plane.

72. Why is color Doppler often turned off during transverse compression imaging?  
To avoid obscuring the vessel walls and better detect thrombus.

73. What does normal Doppler flow in leg veins look like?  
Phasic—flow varies with respiration and stops during breath-holding.

74. What is the term for increased Doppler flow after squeezing the limb below the transducer?  
Augmentation.

75. What does echogenic material in the vein lumen with non-compressibility suggest?  
The presence of a thrombus.

76. What is the primary goal of initiating anticoagulation therapy in a patient with PE or DVT?  
To prevent clot growth and reduce the risk of embolization.

77. What medication is typically used first for immediate anticoagulation in DVT or PE?  
Heparin is used for rapid anticoagulation via IV.

78. How long is anticoagulation therapy typically continued for a first-time DVT or PE?  
Usually about 3 to 6 months.

79. What is the function of Warfarin (Coumadin) in DVT management?  
It is an oral anticoagulant used for long-term clot prevention.

80. What role do pneumatic compression cuffs play in DVT prevention?  
They promote venous return and prevent blood stasis in immobile patients.

81. Why is elevation of the legs recommended in DVT prevention?  
It improves venous return and reduces pooling of blood in the lower extremities.

82. What is the mechanism of action of heparin in preventing clot formation?
Heparin enhances the activity of antithrombin III, inhibiting thrombin and clotting factors.

83. What is the primary laboratory value monitored during heparin therapy?  
Activated Partial Thromboplastin Time (aPTT).

84. Why must patients on Warfarin monitor their INR levels?  
To ensure blood is not too thin or too thick; maintaining therapeutic range reduces clot risk.

85. What lifestyle modification helps reduce DVT risk in sedentary individuals?  
Frequent movement or walking to improve circulation.

86. What is the importance of compression stockings in DVT management?  
They help prevent post-thrombotic syndrome and improve venous return.

87. Why is long-term immobility a risk factor for DVT?  
It leads to venous stasis, one of the components of Virchow’s triad.

88. What are the components of Virchow’s triad?  
Venous stasis, endothelial injury, and hypercoagulability.

89. How does pregnancy increase the risk of DVT?  
Pregnancy causes hypercoagulability and decreased venous return from pelvic compression.

90. What is the typical clinical presentation of a lower-extremity DVT?  
Swelling, pain, warmth, and redness in one leg.

91. What is the diagnostic imaging test of choice for DVT?  
Venous duplex ultrasound.

92. What is the role of a D-dimer test in low-risk DVT patients?  
A negative result helps rule out the need for further imaging.

93. When should imaging be performed despite a negative D-dimer?  
If the clinical suspicion of DVT remains high.

94. Why is DVT more likely in the left leg during pregnancy?  
Due to compression of the left iliac vein by the gravid uterus and right iliac artery.

95. What are collateral veins and when do they develop?  
Alternate pathways for blood flow that develop when a vein is chronically obstructed.

96. What are post-thrombotic complications of DVT?  
Chronic swelling, skin changes, and venous ulcers.

97. What is the primary risk of untreated DVT?  
Development of a potentially fatal pulmonary embolism.

98. What is the clinical significance of calf pain on dorsiflexion (Homan’s sign)?  
Though historically associated with DVT, it is nonspecific and not reliable.

99. Why is it important to assess for bilateral leg symptoms in suspected DVT?  
DVT is usually unilateral; bilateral symptoms may suggest another condition like heart failure.

100. What is a vena cava filter (IVC filter) used for in DVT management?  
To prevent emboli from reaching the lungs in patients who cannot take anticoagulants.

Final Thoughts

Deep vein thrombosis (DVT) is a condition that extends beyond the circulatory system and has a major effect on respiratory health. When a clot forms in a deep vein, the danger lies in its potential to travel to the lungs and cause a pulmonary embolism, which can be life-threatening.

For respiratory therapists, this connection highlights the importance of vigilance and early recognition of warning signs. By collaborating with the healthcare team, supporting preventive measures, and responding promptly to changes in respiratory status, RTs can play a vital role in reducing risks and achieving better patient outcomes.